The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-20-am]Pharmacotherapy (Oncology)

Fri. Mar 28, 2025 1:15 PM - 2:51 PM JST
Fri. Mar 28, 2025 4:15 AM - 5:51 AM UTC
Room 20 (FUKUOKA SUNPALACE: Palace RoomB [2F])
Chair: Katsunori Nakamura, Takashi Kato
1:15 PM - 1:27 PM JST(4:15 AM - 4:27 AM UTC)

[28-20-pm01S]Cumulative risk and predictors of urinary protein expression during long-term anti-VEGF treatment in patients with RAS-mutant colorectal cancer

○Yuto Miura1, Misato Kani1, Daichi Watanabe2, Hironori Hujii2, Yunami Yamada2, Koichi Ohata2, Chiemi Hirose2, Hirotoshi Iihara2, Wakana Chikaishi3, Jesse Yu Tajima3, Akiyoshi Makiyama4, Nobuhisa Matsuhashi3, Ryo Kobayashi1,2, Akio Suzuki1,2 (1. Gifu. Pharm. Univ., 2. Dept. Pharm. Gifu. Univ. Hosp, 3. Grad. Sch. Med. Gifu Univ., 4. Cancer Cent. Gifu Univ. Hosp.)
1:27 PM - 1:39 PM JST(4:27 AM - 4:39 AM UTC)

[28-20-pm02S]A case of mantle cell lymphoma evaluated for blood levels of pirtobrutinib

○Yoshito Gando1, Takeo Yasu2, Masao Tsukada3 (1. Grad. Sch. Pharm. Sci., Meiji Pharmaceutical University, 2. Meiji Pharmaceutical University, 3. Department of Hematology, Tokyo Metropolitan Tama Medical Center)
1:39 PM - 1:51 PM JST(4:39 AM - 4:51 AM UTC)

[28-20-pm03S]Factors affecting delayed recovery from neutropenia in patients with pancreatic cancer receiving gemcitabine plus nab-paclitaxel

○Naoko Yoshida1, Shungo Imai1, Kazuyoshi Kawakami2, Takashi Yokokawa2, Masashi Nakamura2, Takeshi Aoyama2, Hisanori Shimizu2, Ryoichi Naito1, Minori Teramae1, Masami Tsuchiya1, Hayato Kizaki1, Masato Ozaka3, Naoki Sasahira3, Masakazu Yamaguchi2, Satoko Hori1 (1. Keio Univ. Pharm., 2. Cancer Institute Hospital of JFCR. Pharm., 3. Cancer Institute Hospital of JFCR. Gastroenterology.)
1:51 PM - 2:03 PM JST(4:51 AM - 5:03 AM UTC)

[28-20-pm04S]The mechanism of lysosomal escape of auristatins into the cytoplasm

○Naoki Saito1, Naotaka Takahashi2, Ryuto Tomabechi2,3, Keisuke Kiyomiya2, Hisanao Kishimoto1,2, Kei Higuchi1,2, Katsuhisa Inoue1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Pharm., 2. Pharm. Sci., Tokyo Univ. Pharm., 3. Pharm. Sci., Kitasato Univ.)
2:03 PM - 2:15 PM JST(5:03 AM - 5:15 AM UTC)

[28-20-pm05]An elderly patient with diffuse large B-cell lymphoma in whom Pegfilgrastim Prophylaxis did not prevent severe neutropenia caused by the Pola-R-CHP Regimen.

○Naoko Konno1, Naomi Ise2, Masako Takahashi2, Norimichi Tada3 (1. Pharm., Intern. Med. Sato Hosp., 2. Nurs. Dept., Intern. Med. Sato Hosp., 3. Director, Intern. Med. Sato Hosp.)
2:15 PM - 2:27 PM JST(5:15 AM - 5:27 AM UTC)

[28-20-pm06S]Establishing novel molecular-targeted therapy based on the tumor suppressor gene CYLD to overcome cross-resistance between chemotherapy and radiotherapy

○Kou Yonemaru1, Naoki Suenaga1,2, Ayumi Kanemaru1,3, Hideyuki Saito1,4, Hirofumi Jono1,4 (1. Department of Clinical Pharmaceutical Sciences, Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Gofuku Pharm., 3. Clinical Research, Innovation and Education Center, Tohoku Univ. Hospital, 4. Department of Pharmacy, Kumamoto Univ. Hospital)
2:27 PM - 2:39 PM JST(5:27 AM - 5:39 AM UTC)

[28-20-pm07S]Functional changes in variant enzymes in 48 TPMT gene polymorphisms identified in large-scale Japanese genome analysis

○Yuma Sato1, Eiji Hishinuma2,3, Akiko Ueda2, Kai Obuchi1, Yuma Suzuki1, Yuki Ohmori1, Kento Terauchi1, Masahiro Hiratsuka1,2,3,4 (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. INGEM, Tohoku Univ., 3. ToMMo, Tohoku Univ., 4. Depart. Pharm. Sci., Tohoku Univ. Hosp.)
2:39 PM - 2:51 PM JST(5:39 AM - 5:51 AM UTC)

[28-20-pm08S]Research and development of freezing and thawing technology for highly activated NK-like cells (GAIA-102) with a focus on energy metabolism

○Kenta Ishimoto1, Yui Harada1, Yosuke Morodomi1, Situo Zheng1, Noriko Yasuda1, Yoshikazu Yonemitsu1 (1. Grad.Sch.Pharm.Sci., Kyushu Univ.)
Back to Category List